MolPharm xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by VENTER, J. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by VENTER, J. C.

Molecular Pharmacology, Vol 14, 562-574, Copyright © 1978 by the American Society for Pharmacology and Experimental Therapeutics

Cardiac Sites of Catecholamine Action: Diffusion Models for Soluble and Immobilized Catecholamine Action on Isolated Cat Papillary Muscles

J. CRAIG VENTER 1

1 Department of Pharmacology and Therapeutics, State University of New York at Buffalo School of Medicine, Buffalo, New York 14214

Models for isoproterenol and polymer-immobilized isoproterenol diffusion into cat cardiac muscle have been developed by applying the diffusion rates in water and the tortuosity factor for cat cardiac muscle extracellular diffusion. The theoretical extent of drug diffusion into cardiac muscle with time has been compared with the kinetics of cyclic 3',5'-AMP formation and the development of the positive inotropic response to these agents. These studies indicate that peak cardiac inotropic responses may be obtained in cat papillary muscles when the majority of drug molecules are still at the muscle surface and less than 40% of the equilibrium concentration is present in the tissue. The maximum cyclic AMP response occurs with less than 15% of the equilibrium concentration of isoproterenol present and with the majority of the muscle cells exposed to subthreshold levels of drug. These findings suggest that under non-steady-state conditions soluble isoproterenol as well as immobilized catecholamines may cause increased contractility by propagation mechanisms. Biochemical events such as increases in the concentration of cyclic AMP may not reflect events occurring throughout the cardiac muscle. The diffusion arguments indicate that the common assumptions concerning a homogeneous distribution of drug-receptor interactions producing cardiac contractile events oversimplify the events that occur under actual experimental conditions. A model for glass bead-immobilized catecholamine action based on catecholamine leakage is also presented. It indicates that while massive drug leakage does not account for the biological responses of these agents, it may be impossible to elucidate the exact mode of drug action in the microenvironment enveloping the bead surface.

Submitted on October 14, 1977
Accepted on March 6, 1978







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1978 by the American Society for Pharmacology and Experimental Therapeutics